SSCB – Swiss Stem Cells Biotech was set up in 2005 within Cardiocentro Ticino in Lugano, a highly specialized hospital with a strong research vocation, where the first transplant of autologous stem cells in Switzerland was carried out, in 2004, into a heart suffering from myocardial infarction. Afterwards SSCB moved into Swiss Institute for Regenerative Medicine (SIRM), state-of-the-art biomedical research institute.
The Banking department of SSCB – Swiss Stem Cells Biotech separates and preserves Stem Cells from cord blood and cord tissue at birth. Stem Cells will be available for use in the future to treat and maybe save the life of the newborn they were taken from, even when he or she becomes a child or an adult.
Stem Cells stored at SSCB are the exclusive property of the people who have deposited them and they can decide to withdraw them at any time.
Swiss Stem Cells Biotech has been the first Swiss facility to offer a private service for umbilical cord stem cell storage.
Due to the expanding activity and commitment to constantly maintain the highest quality and safety standards, end 2017 SSCB decided to move its offices, laboratories and storage facility in the new 1’500 m2 headquarter based in Vacallo - Canton of Ticino.
All the process and storage are entirely performed in our laboratory based in Switzerland – Canton of Ticino – and fully owned by SSCB.
1'500 square meters of laboratories dedicated to cord blood processes, stem cells extraction, quality controls and samples storage. After 4 years from the first move SSCB needed a bigger facility which allowed to perform efficiently and effectively its current activities but at the same time guarantee the development of its strategy. In fact, SSCB is focused not only on the storage but also on the release of different types of Stem Cells.
Every 3 years FACT-NetCord inspects the premises to check that the quality standards are constantly maintained and improved. This is the maximum guarantee of the level of quality reached by SSCB.
Due to the expansion of the activities, a move to a bigger and more advanced premises was necessary. The Taverne facility was based in the Swiss Institute for Regenerative Medicine, the ideal solution for SSCB, always oriented towards research.
New service offered by SSCB in order to take care of its customers offering free consultation on clinical trials using stem cells that are currently underway or are being launched worldwide.
An extraordinary success for SSCB. SSCB was the first private biobank in Europe to have been accredited by FACT-NetCord. This is the maximum guarantee of the level of quality reached by SSCB.
Swissmedic recognized the quality of SSCB in the process and storage of samples of stem cells from umbilical cord blood in the Swiss Territory, making it possible to import samples from all over Europe.
SSCB is born as a spin off of CARDIOCENTRO TICINO based in Lugano.